Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 223

1.

Revisiting a dogma: similar survival of patients with small bowel and gastric GIST. A population-based propensity score SEER analysis.

Guller U, Tarantino I, Cerny T, Ulrich A, Schmied BM, Warschkow R.

Gastric Cancer. 2015 Dec 9. [Epub ahead of print]

PMID:
26649434
2.

Using lung cancer mortality to indirectly approximate smoking patterns in space.

Jürgens V, Ess S, Schwenkglenks M, Cerny T, Vounatsou P.

Spat Spatiotemporal Epidemiol. 2015 Jul-Oct;14-15:23-31. doi: 10.1016/j.sste.2015.06.003. Epub 2015 Jul 13.

PMID:
26530820
3.

Population-based SEER trend analysis of overall and cancer-specific survival in 5138 patients with gastrointestinal stromal tumor.

Güller U, Tarantino I, Cerny T, Schmied BM, Warschkow R.

BMC Cancer. 2015 Jul 30;15:557. doi: 10.1186/s12885-015-1554-9.

4.

Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy.

Haaß W, Kleiner H, Weiß C, Haferlach C, Schlegelberger B, Müller MC, Hehlmann R, Hofmann WK, Fabarius A, Seifarth W; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung; German CML Study Group.

PLoS One. 2015 Jun 18;10(6):e0129648. doi: 10.1371/journal.pone.0129648. eCollection 2015.

5.

[Osteosarcomas: very rare but curable with your help].

Cerny T.

Praxis (Bern 1994). 2015 Jun 17;104(13):657. doi: 10.1024/1661-8157/a002069. German. No abstract available.

PMID:
26081376
6.

Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy.

Joerger M, Huitema AD, Boot H, Cats A, Doodeman VD, Smits PH, Vainchtein L, Rosing H, Meijerman I, Zueger M, Meulendijks D, Cerny TD, Beijnen JH, Schellens JH.

Cancer Chemother Pharmacol. 2015 Apr;75(4):763-72. doi: 10.1007/s00280-015-2698-7. Epub 2015 Feb 13.

PMID:
25677447
7.

Prognostic Relevance of Palliative Primary Tumor Removal in 37,793 Metastatic Colorectal Cancer Patients: A Population-Based, Propensity Score-Adjusted Trend Analysis.

Tarantino I, Warschkow R, Worni M, Cerny T, Ulrich A, Schmied BM, Güller U.

Ann Surg. 2015 Jul;262(1):112-20. doi: 10.1097/SLA.0000000000000860.

PMID:
25373464
8.

A Bayesian generalized age-period-cohort power model for cancer projections.

Jürgens V, Ess S, Cerny T, Vounatsou P.

Stat Med. 2014 Nov 20;33(26):4627-36. doi: 10.1002/sim.6248. Epub 2014 Jul 3.

PMID:
24996118
9.

Diffuse large B-cell lymphoma in elderly patients: a retrospective analysis.

Diem S, Ess S, Cerny T, Früh M, Hitz F.

Eur J Intern Med. 2014 Jul;25(6):577-82. doi: 10.1016/j.ejim.2014.05.001. Epub 2014 May 28.

PMID:
24881010
10.

Discrete improvement in racial disparity in survival among patients with stage IV colorectal cancer: a 21-year population-based analysis.

Castleberry AW, Güller U, Tarantino I, Berry MF, Brügger L, Warschkow R, Cerny T, Mantyh CR, Candinas D, Worni M.

J Gastrointest Surg. 2014 Jun;18(6):1194-204. doi: 10.1007/s11605-014-2515-3. Epub 2014 Apr 15.

PMID:
24733258
11.

Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV.

Proetel U, Pletsch N, Lauseker M, Müller MC, Hanfstein B, Krause SW, Kalmanti L, Schreiber A, Heim D, Baerlocher GM, Hofmann WK, Lange E, Einsele H, Wernli M, Kremers S, Schlag R, Müller L, Hänel M, Link H, Hertenstein B, Pfirrman M, Hochhaus A, Hasford J, Hehlmann R, Saußele S; German Chronic Myeloid Leukemia Study Group; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung (SAKK).

Ann Hematol. 2014 Jul;93(7):1167-76.

12.

Off-label use of anticancer drugs in eastern Switzerland: a population-based prospective cohort study.

Joerger M, Schaer-Thuer C, Koeberle D, Matter-Walstra K, Gibbons-Marsico J, Diem S, Thuerlimann B, Cerny T.

Eur J Clin Pharmacol. 2014 Jun;70(6):719-25. doi: 10.1007/s00228-014-1662-5. Epub 2014 Mar 11.

PMID:
24609468
13.

Neuroborreliosis Mimicking Leptomeningeal Carcinomatosis in a Patient With Breast Cancer: A Case Report.

Fischer S, Weber J, Senn-Schönenberger I, Cerny T, Hundsberger T.

J Investig Med High Impact Case Rep. 2014 Mar 28;2(1):2324709614529417. doi: 10.1177/2324709614529417. eCollection 2014 Jan-Mar.

14.

Outcome of mantle cell lymphoma patients treated at a single institution over the past decade.

Hitz F, Diem S, Haile SR, Ess S, Cerny T, Mey U.

Hematol Oncol. 2014 Dec;32(4):192-6. doi: 10.1002/hon.2123. Epub 2013 Dec 11.

PMID:
24338732
15.

Spiritual experiences of transcendence in patients with advanced cancer.

Renz M, Mao MS, Omlin A, Bueche D, Cerny T, Strasser F.

Am J Hosp Palliat Care. 2015 Mar;32(2):178-88. doi: 10.1177/1049909113512201. Epub 2013 Nov 20.

PMID:
24259402
16.

Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunction.

Joerger M, Huitema AD, Koeberle D, Rosing H, Beijnen JH, Hitz F, Cerny T, Schellens JH, Gillessen S.

Cancer Chemother Pharmacol. 2014 Jan;73(1):113-24. doi: 10.1007/s00280-013-2327-2. Epub 2013 Oct 29.

PMID:
24166106
17.

Relative survival is an adequate estimate of cancer-specific survival: baseline mortality-adjusted 10-year survival of 771 rectal cancer patients.

Tarantino I, Achermann P, Güller U, Ulrich A, Schmied BM, Horber D, Cerny T, Stanga Z, Warschkow R.

Ann Surg Oncol. 2013 Nov;20(12):3877-84. doi: 10.1245/s10434-013-3173-5. Epub 2013 Aug 2.

PMID:
23907315
18.

Modest improvement in overall survival for patients with metastatic pancreatic cancer: a trend analysis using the surveillance, epidemiology, and end results registry from 1988 to 2008.

Worni M, Guller U, White RR, Castleberry AW, Pietrobon R, Cerny T, Gloor B, Koeberle D.

Pancreas. 2013 Oct;42(7):1157-63. doi: 10.1097/MPA.0b013e318291fbc5.

PMID:
23867367
19.

Management of elderly patients with advanced non-small cell lung cancer: a single-center experience.

Früh M, Besrour H, Gillessen S, Joerger M, Hitz F, Savidan A, Cerny T, Ess S.

Chemotherapy. 2013;59(1):42-50. doi: 10.1159/000350498. Epub 2013 Jul 2.

PMID:
23838903
20.

Predictors of satisfaction with treatment decision, decision-making preferences, and main treatment goals in patients with advanced cancer.

Hitz F, Ribi K, Li Q, Klingbiel D, Cerny T, Koeberle D.

Support Care Cancer. 2013 Nov;21(11):3085-93. doi: 10.1007/s00520-013-1886-4. Epub 2013 Jul 5.

PMID:
23828394
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk